Seeing Is Believing
Currently, out of the existing stock ratings of Keyur Parekh - 2 which are a Hold (50%), 2 which are a Buy (50%)
Analyst Keyur Parekh works at GOLDMAN SACHS and is covering the Healthcare sector with 5 price targets and ratings displayed on 4 stocks.
Most recent stock forecast was given on NVS, Novartis AG at 26-Jan-2022.
Analyst best performing recommendations are on NVS (NOVARTIS AG).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
80
$11.78 (17.27%)
2 days ago
3/5 (60%)
$17.92 (32.06%)
161
Buy
120.34
2 months 13 days ago
0/2 (0%)
$56.72 (106.69%)
Hold
2 months 15 days ago
0/2 (0%)
$56.95 (106.34%)
Buy
158.61
2 months 22 days ago
0/3 (0%)
$77.98 (168.75%)
Buy
80
$11.78 (17.27%)
85
4 months 1 days ago
1/3 (33.33%)
$9.27 (13.19%)
232
What Year was the first public recommendation made by Keyur Parekh?